Advertisement

Topics

Scleroderma Research Foundation Company Profile

05:04 EDT 20th April 2018 | BioPortfolio


News Articles [664 Associated News Articles listed on BioPortfolio]

Stem Cell Transplant Shows Promise for Immune Disorder Scleroderma

WEDNESDAY, Jan. 3, 2018 -- Stem cell transplants could offer new hope for people with a severe form of scleroderma -- a debilitating and deadly condition that affects the immune system, a new study su...

Scleroderma Research Foundation's Star-Studded Cool Comedy – Hot Cuisine Event Comes to New York City Dec. 5

Scleroderma Research Foundation has raised over $45 million since 1987 to fund critical research Scleroderma Research Foundation (SRF) Board Member Bob Saget will host ...

New HSS study finds hope in understanding and better treating scleroderma

(Hospital for Special Surgery) Researchers at HSS find a potential cause and treatment lead for scleroderma.

New HSS study may signal hope for patients suffering from scleroderma

Scleroderma is a terribly debilitating disease with no effective treatments and the mortality rates are still upwards of 20%-50%, the highest of any rheumatic disease.

Scleroderma study: Hope for a longer life for patients with rare autoimmune disorder

(University of Virginia Health System) The approach could represent the first new treatment to improve survival in patients with severe scleroderma in more than four decades.

Stem cell transplant is better than drug therapy for scleroderma

Scleroderma with internal organ involvement is a debilitating and lethal autoimmune disorder with few effective treatments. But a study has now found new cause for optimism using an aggressive stem ce...

Shock-wave therapy improves finger ulcers in patients with scleroderma

SAN DIEGO — Low-level extracorporeal shock-wave therapy demonstrated clinically meaningful improvement in patients with systemic scleroderma and finger ulcers, according to findings presented at th...

Autologous stem-cell transplantation improves survival in scleroderma patients: The SCOT trial

1. Scleroderma patients treated with myeloablative autologous stem-cell transplantation experienced significantly higher rates of disease-free survival at 52 months post-treatment compared to those tr...

PubMed Articles [1062 Associated PubMed Articles listed on BioPortfolio]

Improving life expectancy of patients with scleroderma. Results from the South Australian Scleroderma Register.

Scleroderma is a rare connective tissue disorder characterised by inflammation, vasculopathy and excessive fibrosis. Patients with scleroderma are known to have decreased life expectancy.

Detection of autoimmune antibodies in localized scleroderma by synthetic oligonucleotide antigens.

In this study, we developed a series of synthetic oligonucleotides that allowed us to investigate the details on the antigen recognition by autoimmune antibodies in localized scleroderma subjects. Bes...

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

Despite current therapies, diffuse cutaneous systemic sclerosis (scleroderma) often has a devastating outcome. We compared myeloablative CD34+ selected autologous hematopoietic stem-cell transplantati...

"I'm still dad": The Impact of Scleroderma on being a Father.

The purpose of this study was to describe the experiences of fathers with scleroderma. Ten fathers with scleroderma were interviewed by telephone. Interviews were tape-recorded and transcribed verbati...

Impact of Radiation Therapy on Scleroderma and Cancer Outcomes in Scleroderma Patients with Breast Cancer.

We examined SSc patients with breast cancer to 1) identify the prevalence of radiation complications and 2) examine SSc outcomes in SSc patients who received radiation therapy (RT) as part of their ca...

Clinical Trials [1340 Associated Clinical Trials listed on BioPortfolio]

The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)

The Scleroderma bioreposiTOry and Pathogenesis Study (STOP Scleroderma) will help researchers use clinical data and human biospecimens to investigate why scleroderma patients develop certa...

Scleroderma Registry & Repository at the Hospital for Special Surgery

The overall objective of the Scleroderma Registry is to support and promote the basic science and clinical research of this complex rheumatic disease at the Hospital for Special Surgery (H...

Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Controls

Scleroderma is an autoimmune disease of unknown origin. Recently, the role of environmental factors, and particularly toxic drug exposure, in the genesis of scleroderma has been suggested....

Functional Luminal Imaging Probe (FLIP) Topography Use in Patients With Scleroderma and Trouble Swallowing

FLIP topography has been FDA cleared to evaluate a variety of esophageal conditions, but has never been evaluated in patients with scleroderma. The investigators hope to evaluate this tech...

Scleroderma Registry

Scleroderma is likely caused by a combination of factors, including an external trigger (infection or other exposure) and a genetic predisposition. The Scleroderma Registry will conduct ge...

Companies [2406 Associated Companies listed on BioPortfolio]

Scleroderma Foundation, Texas Bluebonnet Chapter

The Scleroderma Foundation is a 501(c)3 non-profit organization dedicated to serving the needs and interests of all those affected by scleroderma. Headquartered in Danvers, Mass., the Foundation's 22...

Scleroderma Research Foundation

The Scleroderma Foundation

Scleroderma Foundation, Southern California Chapter

Spendlove Research

The Spendlove Research Foundation was founded in 1989 and is funded through an endowment established by Dr. Rex S. and Reta Spendlove and family. Dr. Spendlove is the Founder of Hyclone Laboratories, ...

More Information about "Scleroderma Research Foundation" on BioPortfolio

We have published hundreds of Scleroderma Research Foundation news stories on BioPortfolio along with dozens of Scleroderma Research Foundation Clinical Trials and PubMed Articles about Scleroderma Research Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Scleroderma Research Foundation Companies in our database. You can also find out about relevant Scleroderma Research Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record